{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:50:34Z","timestamp":1791402634091,"version":"4.3.3"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["XD1807"],"award-info":[{"award-number":["XD1807"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010010","name":"Shanxi Province Science Foundation for Youths","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013318","name":"Shanxi Province Science and Technology Department","doi-asserted-by":"publisher","award":["201901D211314"],"award-info":[{"award-number":["201901D211314"]}],"id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.clim.2022.109173","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T11:29:38Z","timestamp":1667734178000},"page":"109173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies"],"prefix":"10.1016","volume":"245","author":[{"given":"Yongbo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clim.2022.109173_bb0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: from autoantibodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.clim.2022.109173_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol"},{"issue":"10","key":"10.1016\/j.clim.2022.109173_bb0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2022.109173_bb0020","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3389\/fmicb.2018.02627","article-title":"Altered Gut Microbiota in Myasthenia Gravis","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.clim.2022.109173_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/ICU.0b013e328358b94a","article-title":"Ocular myasthenia gravis","volume":"23","author":"Vaphiades","year":"2012","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.clim.2022.109173_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/WNO.0000000000000350","article-title":"Ocular Myasthenia Gravis: Toward a Risk of Generalization Score and Sample Size Calculation for a Randomized Controlled Trial of Disease Modification","volume":"36","author":"Wong","year":"2016","journal-title":"J Neuroophthalmol."},{"key":"10.1016\/j.clim.2022.109173_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2019.09.019","article-title":"Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody","volume":"209","author":"Apinyawasisuk","year":"2020","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"10.1016\/j.clim.2022.109173_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s13311-015-0398-y","article-title":"Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis","volume":"13","author":"Guptill","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.clim.2022.109173_bb0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ahg.12262","article-title":"Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis","volume":"82","author":"Fang","year":"2018","journal-title":"Ann. Hum. Genet."},{"issue":"9","key":"10.1016\/j.clim.2022.109173_bb0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0043-116387","article-title":"Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies","volume":"55","author":"Kang","year":"2017","journal-title":"Z. Gastroenterol."},{"issue":"3","key":"10.1016\/j.clim.2022.109173_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.aller.2017.05.010","article-title":"Change in gut microbiota for eczema: Implications for novel therapeutic strategies","volume":"46","author":"Kang","year":"2018","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"10.1016\/j.clim.2022.109173_bb0060","doi-asserted-by":"crossref","first-page":"803101","DOI":"10.3389\/fimmu.2021.803101","article-title":"Gut Microbiota as Regulators of Th17\/Treg Balance in Patients With Myasthenia Gravis","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2022.109173_bb0065","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1038\/s41598-018-32700-y","article-title":"Fecal microbiota profile in a group of myasthenia gravis patients","volume":"8","author":"Moris","year":"2018","journal-title":"Sci Rep."},{"issue":"18","key":"10.1016\/j.clim.2022.109173_bb0070","doi-asserted-by":"crossref","first-page":"1901441","DOI":"10.1002\/advs.201901441","article-title":"Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome","volume":"6","author":"Zheng","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.clim.2022.109173_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.564579","article-title":"Differential Gut Microbiota and Fecal Metabolites Related With the Clinical Subtypes of Myasthenia Gravis","volume":"11","author":"Tan","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.clim.2022.109173_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211035657","article-title":"Gut bacterial microbiota in patients with myasthenia gravis: Results from the MYBIOM study","volume":"14","author":"Totzeck","year":"2021","journal-title":"Ther Adv Neurol Disord."},{"issue":"1","key":"10.1016\/j.clim.2022.109173_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12916-021-02034-0","article-title":"Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis","volume":"19","author":"Liu","year":"2021","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.clim.2022.109173_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.clim.2022.109173_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000521358","article-title":"The gut microbiome and hepatocellular carcinoma: Implications for early diagnostic biomarkers and novel therapies","volume":"11","author":"Kang","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clim.2022.109173_bb0100","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.3389\/fimmu.2019.02949","article-title":"Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats","volume":"10","author":"Rinaldi","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2022.109173_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.aller.2017.04.008","article-title":"Future prospect of faecal microbiota transplantation as a potential therapy in asthma","volume":"46","author":"Kang","year":"2018","journal-title":"Allergol. Immunopathol. (Madr)"},{"issue":"2","key":"10.1016\/j.clim.2022.109173_bb0110","article-title":"Gut Microbiota and Parkinson\u2019s Disease: Implications for Faecal Microbiota Transplantation Therapy","volume":"13","author":"Kang","year":"2021","journal-title":"ASN Neuro"},{"issue":"32","key":"10.1016\/j.clim.2022.109173_bb0115","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.3748\/wjg.v27.i32.5362","article-title":"Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer","volume":"27","author":"Kang","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.clim.2022.109173_bb0120","doi-asserted-by":"crossref","first-page":"106020","DOI":"10.1016\/j.phrs.2021.106020","article-title":"Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability","volume":"175","author":"Kang","year":"2022","journal-title":"Pharmacol Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622002546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:10:10Z","timestamp":1761495010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"alternative-id":["S1521661622002546"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109173","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109173"}}